Playback speed
10 seconds
AHA 2024 Insights: Phase 2 Trial of Zerlasiran: Multiple Doses of an siRNA Targeting Lipoprotein(a) Over 60 Weeks
By
AHA 2024 Insights
FEATURING
Steven Nissen
By
AHA 2024 Insights
FEATURING
Steven Nissen
1,135 views
November 19, 2024
Comments 5
Login to view comments.
Click here to Login